tiprankstipranks
Trending News
More News >
Definium Therapeutics (DFTX)
NASDAQ:DFTX

Compare Definium Therapeutics (DFTX) vs. Competitors

Compare
2,209 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Definium Therapeutics
$18.66
$1.86B
-6.51
178.51%
11 Buy
0 Hold
0 Sell
Strong Buy
AnaptysBio
$64.72
$1.86B
-101.81
293.67%
8 Buy
1 Hold
0 Sell
Strong Buy
Enliven Therapeutics
$30.05
$1.80B
-8.42
43.85%
4 Buy
0 Hold
0 Sell
Strong Buy
Tyra Bioscience
$38.18
$2.06B
-13.06
242.11%
10 Buy
0 Hold
0 Sell
Strong Buy
Biohaven Ltd.
$8.96
$1.35B
-1.64
-68.83%
9 Buy
3 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$85.32
$943.45M
363.36%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DFTX
Definium Therapeutics
18.66
11.94
177.68%
ANAB
AnaptysBio
64.72
47.64
278.92%
ELVN
Enliven Therapeutics
30.05
8.97
42.55%
TYRA
Tyra Bioscience
38.18
27.49
257.16%
BHVN
Biohaven Ltd.
8.96
-19.58
-68.61%
INBX
Inhibrx Biosciences Inc
64.87
50.52
352.06%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts